Study guide
8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act
Professional and Linguistic Assessments Board Part 1 PLAB 1
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the PLAB 1 Exam
2 Chapter 1: Acute Medicine, Resuscitation & Clinical Emergencies
1.1 The ABCDE Approach, Adult Resuscitation & Shock 1.2 Sepsis, Sepsis Six Protocol & Septic Shock 1.3 Anaphylaxis & Acute Airway Emergencies 1.4 Clinical Toxicology & Acute Poisoning 1.5 Major Trauma, Head Injury, Burns & Environmental Emergencies
3 Chapter 2: Cardiovascular Medicine & Vascular Disorders
2.1 Acute Coronary Syndromes (STEMI & NSTEMI/Unstable Angina) 2.2 Heart Failure & Cardiogenic Shock 2.3 Cardiac Arrhythmias & Syncope 2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies 2.5 Infective Endocarditis, Pericardial Disease, Myocarditis & Cardiomyopathies 2.6 Peripheral Arterial Disease, Aortic Aneurysm & Venous Disease
4 Chapter 3: Respiratory Medicine
3.1 Asthma: Diagnostic Criteria, Chronic Stepping & Acute Exacerbations 3.2 COPD: Staging, Long-Term Management & Acute Exacerbations 3.3 Pneumonia & Lower Respiratory Tract Infections 3.4 Venous Thromboembolism, Pleural Disease & Pneumothorax 3.5 Lung Cancer, Interstitial & Suppurative Lung Disease, Sleep Apnoea & Respiratory Failure
5 Chapter 4: Gastroenterology, Hepatobiliary & General Surgery
4.1 Upper Gastrointestinal Bleeding & Dyspepsia 4.2 Lower Gastrointestinal Bleeding, IBD & Colorectal Malignancy 4.3 Acute Abdomen, Bowel Obstruction & Perforation 4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis 4.5 Functional, Malabsorptive & Infective Bowel Disorders, Anorectal Disease, Hernias & MASLD
6 Chapter 5: Renal Medicine, Urology & Fluid/Electrolyte Balance
5.1 Acute Kidney Injury & KDIGO Staging 5.2 Chronic Kidney Disease & Glomerular Disorders 5.3 Electrolyte Emergencies: Potassium, Sodium & Calcium 5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention 5.5 Urological Cancers, Prostate Disease & Scrotal Emergencies
7 Chapter 6: Endocrinology & Metabolic Medicine
6.1 Diabetes Mellitus: Diagnostic Criteria & Chronic Management 6.2 Diabetic Emergencies: DKA & Hyperosmolar Hyperglycaemic State 6.3 Thyroid Disorders: Hypothyroidism, Thyrotoxicosis & Thyroid Storm 6.4 Adrenal & Pituitary Disorders: Addisonian Crisis & Pituitary Disease
8 Chapter 7: Neurology & Neurosciences
7.1 Acute Stroke, TIA & Intracranial Haemorrhage 7.2 Acute & Chronic Headaches, Giant Cell Arteritis & CNS Infections 7.3 Seizures, Status Epilepticus & Epilepsy Management 7.4 Neuromuscular Disorders & Movement Disorders 7.5 Raised Intracranial Pressure, Brain Tumours, Cranial Nerve Lesions & Spinal Cord Disorders
9 Chapter 8: Psychiatry & Mental Health
8.1 Affective Disorders: Depression, Bipolar Disorder & Suicide Risk Assessment 8.2 Psychosis, Schizophrenia & Acute Agitation 8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act 8.4 Anxiety Disorders, OCD, PTSD, Eating Disorders, Personality Disorders & Somatic Presentations 8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health
10 Chapter 9: Obstetrics, Gynaecology & Sexual Health
9.1 Early Pregnancy: Miscarriage & Ectopic Pregnancy 9.2 Antenatal & Peripartum Emergencies: Pre-Eclampsia & Haemorrhage 9.3 Common Gynaecological Presentations & Gynaecological Oncology 9.4 Contraception, Emergency Contraception & Sexually Transmitted Infections 9.5 Routine Antenatal Care, Labour & Obstetric Emergencies 9.6 Menopause & HRT, Subfertility, Prolapse & Urinary Incontinence
11 Chapter 10: Paediatrics & Child Health
10.1 The Febrile Child, Sepsis & Meningococcal Disease 10.2 Paediatric Respiratory Distress: Croup, Bronchiolitis & Wheeze 10.3 Paediatric Abdominal Emergencies, Dehydration & Neonatal Jaundice 10.4 Child Safeguarding, Non-Accidental Injury & Developmental Milestones 10.5 Neonatology & Congenital Heart Disease 10.6 Paediatric Orthopaedics, Growth, Childhood Cancer & Common Chronic Problems
12 Chapter 11: Musculoskeletal Medicine & Rheumatology
11.1 Inflammatory Arthropathies & Connective Tissue Diseases 11.2 Crystal Arthropathies (Gout & Pseudogout) & Septic Arthritis 11.3 Osteoporosis, Common Fractures & Orthopaedic Emergencies 11.4 Osteoarthritis, Low Back Pain, Polymyalgia Rheumatica, Fibromyalgia & Soft Tissue Disorders
13 Chapter 12: Dermatology, ENT & Ophthalmology
12.1 Common Dermatoses & Dermatological Emergencies 12.2 ENT Presentations: Infections, Epistaxis, Vertigo, Hearing Loss & Head and Neck Lumps 12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis 12.4 Sudden & Gradual Vision Loss, Retinal Disorders & the Visual Pathway 12.5 Skin Infections, Infestations, Childhood Rashes & Skin Cancer
14 Chapter 13: Haematology, Oncology & Palliative Care
13.1 Anaemias & Blood Transfusion Medicine 13.2 Haematological Malignancies: Leukaemias, Lymphomas & Myeloma 13.3 Haemostasis, Coagulation Disorders & Anticoagulant Reversal 13.4 Oncological Emergencies & Palliative Symptom Management 13.5 Breast Disease, Cancer Screening & Suspected Cancer Referral
15 Chapter 14: Perioperative Care, Safe Prescribing & Clinical Pharmacology
14.1 Preoperative Assessment & Perioperative Medication Management 14.2 Postoperative Complications & Fluid Therapy 14.3 High-Risk Medications & Therapeutic Drug Monitoring 14.4 Safe Prescribing Principles & Antimicrobial Stewardship
16 Chapter 15: Medical Ethics, Law & UK Clinical Practice
15.1 GMC Good Medical Practice, Professionalism, Teamwork & Quality Improvement 15.2 Consent, Capacity & the Mental Capacity Act 2005 15.3 Confidentiality, Statutory Reporting & DVLA Regulations 15.4 End-of-Life Decisions, DNACPR, Organ Donation, Adult Safeguarding & Domestic Abuse
17 Chapter 16: Infectious Diseases, Travel Medicine & Infection Prevention
16.1 Tuberculosis, HIV, Hepatitis B & C and Needlestick Injuries 16.2 Fever in the Returning Traveller, Zoonoses, Notifiable Diseases & Infection Prevention
18 Chapter 17: Older Adults, Population Health, Genetics & Clinical Imaging
17.1 Frailty, Falls, Polypharmacy, Continence & Pressure Ulcers 17.2 Medical Statistics, Diagnostic Tests & Critical Appraisal 17.3 Public Health, Screening Principles, Health Inequalities & Health Promotion 17.4 Genetics, Genomics & Pharmacogenomics 17.5 Clinical Imaging: Choosing Tests, Radiation Safety & Interpreting X-rays
8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act
Key Takeaways Explain This Topic AI
Delirium is an acute, fluctuating syndrome characterized by impaired attention and disturbed sleep-wake cycles, requiring systematic identification and correction of underlying triggers using the PINCH ME framework.
Dementia is characterized by progressive cognitive impairment in clear consciousness; distinctive subtypes include Alzheimer's (amnestic), Vascular (stepwise), Lewy Body (visual hallucinations and extreme neuroleptic sensitivity), and Frontotemporal (early disinhibition).
Alcohol withdrawal manifests with autonomic hyperactivity, potential withdrawal seizures at 24–48 hours, and Delirium Tremens at 48–72 hours; management centers on fixed-dose reducing benzodiazepines (chlordiazepoxide) and parenteral thiamine (Pabrinex) before glucose.
Wernicke's encephalopathy presents with the classic triad of acute confusion, ataxia, and ophthalmoplegia/nystagmus; failure to administer high-dose parenteral thiamine precipitates irreversible Korsakoff's psychosis.
The Mental Health Act 1983 provides legal frameworks for civil detention: Section 2 (assessment, up to 28 days), Section 3 (treatment, up to 6 months), Section 4 (emergency, 72 hours), Section 5(2) (doctor's holding power, 72 hours), and Section 136 (police place of safety, 24 hours).
Last updated: October 2026
Cognitive Disorders, Substance Misuse & the Mental Health Act
Cognitive impairment and substance withdrawal represent frequent challenges across acute hospital wards. Clinicians must rapidly differentiate acute, reversible confusional states (delirium) from progressive neurodegenerative syndromes (dementia), recognize life-threatening alcohol withdrawal emergencies to prevent permanent neurological damage, and apply the civil detention powers of the Mental Health Act 1983 safely, lawfully, and proportionately.
Delirium (Acute Confusional State): Phenomenology & Assessment
In accordance with NICE guideline CG103 (Delirium: prevention, diagnosis and management) and NICE guideline NG97 (Dementia) , delirium is an acute neuropsychiatric syndrome characterized by concurrent disturbances of consciousness, attention, perception, and the sleep-wake cycle, precipitated by underlying systemic somatic illness.
Core Clinical Characteristics
Acute Onset & Fluctuating Course: Develops over hours to days, characteristically fluctuating over 24 hours and worsening in the evening ( "sundowning" ).
Impaired Attention & Concentration: The cardinal feature; patients cannot initiate, maintain, or shift attention.
Perceptual Abnormalities: Visual illusions and vivid hallucinations (frequently animals or unfamiliar people).
Sleep-Wake Reversal: Fragmented night sleep with daytime somnolence.
Clinical Subtypes
Hyperactive Delirium (~20%): Psychomotor agitation, restlessness, hypervigilance, and prominent hallucinations.
Hypoactive Delirium (~50%): Psychomotor slowing, somnolence, lethargy, and withdrawal. Frequently missed or misdiagnosed as depression , carrying high hospital mortality.
Mixed Delirium (~30%): Alternating between hyperactive and hypoactive states.
Assessment & The PINCH ME Framework
The 4AT screening tool evaluates Alertness, AMT4 (age, DOB, place, year), Attention (months backwards), and Acute change/fluctuation ( score ≥4 indicates delirium ).
PINCH ME Etiological Mnemonic:
P – Pain: Undiagnosed fractures, urinary retention, postoperative pain.
I – Infection: UTI, pneumonia, cellulitis, intra-abdominal sepsis.
N – Nutrition / Dehydration: Poor oral fluid/caloric intake, starvation ketosis.
C – Constipation: Faecal impaction causing severe visceral distress.
H – Hydration / Hypoxia: Hypovolaemia, heart failure, COPD exacerbation, PE.
M – Medication / Polypharmacy: Anticholinergics, sedatives, opiates, corticosteroids, drug withdrawal.
E – Electrolytes / Metabolic: Hyponatraemia, hypercalcaemia, AKI, hypoglycemia, hepatic failure.
Management & Sedation Guidelines
Non-Pharmacological Delirium Bundle (First-Line): Treat underlying somatic causes; clear verbal reorientation, visible clocks/calendars, familiar staff, daytime lighting and night quiet, sensory aids (glasses/hearing aids), early mobilization, avoiding restraints/catheters.
Pharmacological Sedation (Strict Last Resort): Only if imminent severe risk to safety. Low-dose oral haloperidol (0.5 to 1 mg) .
Caution
Antipsychotics in Parkinson's Disease & DLB: NICE CG103 advises using antipsychotics with caution or not at all in Parkinson's disease or dementia with Lewy bodies (DLB): dopamine blockade can cause severe, sometimes fatal neuroleptic sensitivity reactions (rigidity, immobility, falls). Haloperidol should be avoided; if sedation is essential, seek specialist advice (low-dose oral lorazepam 0.5 to 1 mg is commonly used).
Dementia Syndromes: Classification & Differentiation
Dementia is a chronic, progressive global cognitive decline in clear consciousness (sensorium preserved).
Delirium vs Dementia
- Diagnostic Domain Delirium (Acute Confusional State) Dementia (Major Neurocognitive Disorder)
- Onset Acute (hours to days) Insidious (months to years)
- Course Fluctuating over 24 hours; marked "sundowning" Progressive and slowly deteriorating
- Consciousness Altered / clouded ; fluctuates Clear ; sensorium preserved until late stages
Attention Severely impaired ; core cardinal diagnostic sign Intact early on ; preserved until late-stage disease
- Hallucinations Common visual illusions and hallucinations Infrequent early on (except in Lewy Body Dementia)
- Reversibility Potentially fully reversible when trigger treated Irreversible and progressive
- The Four Major Dementia Subtypes
Alzheimer's Disease (~60–70%): Cortical beta-amyloid plaques and hyperphosphorylated tau tangles ; temporoparietal and hippocampal atrophy. Early insidious short-term episodic memory loss , nominal dysphasia, visuospatial disorientation, apraxia. First-line pharmacotherapy: Acetylcholinesterase inhibitors (Donepezil, Rivastigmine, Galantamine) ; Memantine (NMDA antagonist) for moderate-to-severe disease.
Vascular Dementia (~15–20%): Multi-infarct or subcortical ischemic injury. Characterized by stepwise deterioration , early executive dysfunction , psychomotor slowing, and focal neurological signs (brisk reflexes, pseudobulbar palsy). Management: Secondary cardiovascular prevention (antiplatelet, statin, BP control).
Dementia with Lewy Bodies (DLB, ~10–15%): Cortical alpha-synuclein Lewy bodies . Core triad: (1) Fluctuating cognition ; (2) Recurrent, detailed visual hallucinations (people/animals); (3) Spontaneous parkinsonism (rigidity, tremor, bradykinesia) within 1 year of cognitive decline. Associated with REM sleep behavior disorder. Severe neuroleptic sensitivity (antipsychotics strictly contraindicated).
Frontotemporal Dementia (FTD / Pick's Disease, ~5%): Frontal/temporal lobar atrophy (Pick bodies / tau or TDP-43). Younger onset (45–65 years) . Behavioral variant: Early personality changes , social disinhibition, loss of empathy, apathy, hyperorality (craving sweets), compulsive behaviors. Memory and visuospatial abilities preserved early.
- Substance Misuse: Alcohol & Opioid Withdrawal Syndromes
- Alcohol Withdrawal Timeline & Management
Abrupt alcohol cessation removes GABAergic inhibition and triggers an unopposed NMDA glutamatergic storm.
6 to 12 Hours: Autonomic hyperactivity: coarse tremor, sweating, tachycardia, hypertension, nausea, anxiety.
24 to 48 Hours: Withdrawal Seizures: Generalized tonic-clonic seizures, often brief runs (peak at 36 hours).
48 to 72 Hours: Delirium Tremens (DTs): Medical emergency (mortality up to 5%). Gross delirium, severe agitation, tremor, fever, autonomic collapse, and vivid hallucinations ( formication / insects on skin , visual hallucinations).
Management: Grade with CIWA-Ar . Treat with a fixed-dose reducing schedule of Chlordiazepoxide (or Diazepam). In severe liver impairment / cirrhosis, use short-acting agents without active metabolites ( Lorazepam or Oxazepam ).
Wernicke-Korsakoff Syndrome Protocol
Acute thiamine (vitamin B1) deficiency causing petechial haemorrhages in mammillary bodies.
Wernicke's Triad: (1) Acute Confusion / Encephalopathy ; (2) Ataxia (broad-based gait); (3) Ophthalmoplegia / Nystagmus (bilateral 6th nerve palsies).
Important
The Cardinal Thiamine Rule: Administer high-dose parenteral thiamine (IV Pabrinex, 2 pairs TDS for 3–5 days) BEFORE or CONCURRENTLY WITH any intravenous glucose infusion . Administering glucose alone rapidly exhausts residual thiamine cofactors, precipitating fatal brainstem necrosis.
Korsakoff's Psychosis: Chronic irreversible sequela of untreated Wernicke's. Manifests with profound anterograde amnesia , retrograde amnesia, and confabulation (fabricating memories without intent to deceive), with preserved immediate recall.
Opioid Withdrawal Syndrome
Noradrenergic surge causing rhinorrhoea, lacrimation, yawning, piloerection ("cold turkey") , pupillary dilation (mydriasis) , myalgias, abdominal cramps, and diarrhoea. Distressing but not intrinsically life-threatening . Manage with Methadone or Buprenorphine substitution, or Lofexidine (alpha-2 agonist) with loperamide and antiemetics.
Mental Health Act 1983 (Amended 2007) — England & Wales
Governs compulsory assessment, detention, and treatment of mental disorders without consent.
Note
Mental Health Act 2025: The Mental Health Act 2025 received Royal Assent in December 2025 and amends the 1983 Act in phases over several years. Planned changes include a nominated person replacing the nearest relative, tighter detention criteria (risk of serious harm and a reasonable prospect of therapeutic benefit), limits on detaining autistic people and people with a learning disability for treatment without a co-occurring mental disorder, and more frequent tribunal access. Until each provision commences, the sections below (the 1983 Act as amended) remain the operative law.
Key Civil Detention Sections
Section Legal Purpose Maximum Duration Applicant Medical Recommendations Key Clinical & Renewal Rules
Section 2 Admission for Assessment Up to 28 days AMHP (or Nearest Relative) 2 Doctors: One Section 12 approved; one with previous acquaintance (e.g. GP) Cannot be renewed. Allows involuntary psychiatric assessment and treatment.
Section 3 Admission for Treatment of known disorder Up to 6 months AMHP (Nearest Relative consulted; can object) 2 Doctors: One Section 12 approved; appropriate medical treatment must be available Renewable for 6 months, then annually. Treatment without consent allowed for 3 months, then requires SOAD.
Section 4 Emergency Admission for Assessment Up to 72 hours AMHP or Nearest Relative 1 Doctor: Preferably Section 12 approved or acquainted Cannot be renewed. Used when urgent admission is needed and waiting for a 2nd doctor causes serious delay. Converts to S2 upon second medical recommendation.
Section 5(2) Doctor's Holding Power for existing inpatient Up to 72 hours The registered medical practitioner in charge of care (or nominated deputy) 1 Doctor completes statutory Form H1 Cannot be renewed. Authorizes detention to allow formal S2/S3 assessment. Applies only to admitted inpatients; cannot be used in ED or outpatient clinics.
Section 5(4) Nurse's Holding Power for existing inpatient Up to 6 hours Registered Mental Health Nurse (RMN) None (nurse assessment) Cannot be renewed. Ends immediately upon doctor's arrival.
Section 136 Police Power anywhere except a private dwelling (since the Policing and Crime Act 2017) Up to 24 hours (extendable by 12 hours) Police Officer None for removal; assessed at Place of Safety by 1 Doctor and 1 AMHP Cannot be renewed. Person must appear mentally disordered and in immediate need of care/control in a public place.
Mental Capacity Act (MCA) 2005 vs Mental Health Act (MHA) 1983
Mental Capacity Act 2005: Governs decision-specific capacity for physical health treatments in the patient's best interests (using Deprivation of Liberty Safeguards [DoLS] if care amounts to detention).
Mental Health Act 1983: Specifically governs detention and treatment of mental disorders , and can be invoked regardless of capacity . When a patient with a mental disorder requires compulsory psychiatric admission and actively resists, the MHA must be used rather than the MCA.